Akorn (AKRX) Posts Q3 Loss of $0.06, Beats By 2c
More News related to AKRX
- Akorn (AKRX) Posts Q3 Loss of $0.06, Beats By 2c
- Akorn Reports Third Quarter 2009 Financial Results; Launches Two New Products: Ketorolac Tromethamine Ophthalmic and Hydralazine HCL
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Akorn, Inc. Announces Third Quarter 2009 Earnings Release and Conference Call Information
- Akorn (AKRX) Files Shelf Offering of Up To 13.3M Shares
More News related to Earnings
- Afternoon ETF Check: SMH Up; XLF, TAN, EWJ Down
- Unusual 11 Mid-Day Movers 11/24: IWA, DRAM, ABG, TIXC Higher; WH, WMG, ABIO, NYNY Lower
- Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded
- Notable Mergers and Acquisitions of the Day 11/24: WIN/IWA, GMCR/DDRX, PLA
- Morning Movers 11/24: IWA, SEED, FEED, AEZS Higher; WH, ORS, ABIO, GRO, LONG Lower
Akorn, Inc. (NASDAQ: AKRX) reports Q3 loss of $0.06, 2 cents better than the analyst estimate of ($0.08). Revenue for the quarter was $19.4 million, which compares to the estimate of $15.95 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
